Hypoxia inducible factor‐1 activator munc‐18‐interacting protein 3 promotes tumour progression in urothelial carcinoma
Junichi Ikeda(Kansai Medical University), Takeharu Sakamoto(The University of Tokyo)
Cited by 4
Related Papers
The ERK signaling target RNF126 regulates anoikis resistance in cancer cells by changing the mitochondrial metabolic flux
|Cell Discovery|2016|52
NECAB3 Promotes Activation of Hypoxia-inducible factor-1 during Normoxia and Enhances Tumourigenicity of Cancer Cells
|Scientific Reports|2016|36
Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus
|Scientific Reports|2016|18
Pharmacological inhibition of Mint3 attenuates tumour growth, metastasis, and endotoxic shock
|Communications Biology|2021|8
CD155 immunohistochemical expression in upper tract urothelial carcinoma predicts poor prognosis
|Oncology Letters|2022|4